512 related articles for article (PubMed ID: 28865727)
1. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
[TBL] [Abstract][Full Text] [Related]
2. Early Cardiac Mitochondrial Molecular and Functional Responses to Acute Anthracycline Treatment in Wistar Rats.
Pereira GC; Pereira SP; Pereira FB; Lourenço N; Lumini JA; Pereira CV; Bjork JA; Magalhães J; Ascensão A; Wieckowski MR; Moreno AJ; Wallace KB; Oliveira PJ
Toxicol Sci; 2019 May; 169(1):137-150. PubMed ID: 30698778
[TBL] [Abstract][Full Text] [Related]
3. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.
Marques-Aleixo I; Santos-Alves E; Torrella JR; Oliveira PJ; Magalhães J; Ascensão A
Cardiovasc Toxicol; 2018 Feb; 18(1):43-55. PubMed ID: 28536949
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the Keap1/Nrf2-Antioxidant Response System After Chronic Doxorubicin Exposure In Vivo.
Nordgren KKS; Wallace KB
Cardiovasc Toxicol; 2020 Dec; 20(6):557-570. PubMed ID: 32500386
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
[TBL] [Abstract][Full Text] [Related]
8. Editor's Highlight: The Altered DNA Methylome of Chronic Doxorubicin Exposure in Sprague Dawley Rats.
Nordgren KKS; Hampton M; Wallace KB
Toxicol Sci; 2017 Oct; 159(2):470-479. PubMed ID: 28962528
[TBL] [Abstract][Full Text] [Related]
9. The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes.
Hanf A; Oelze M; Manea A; Li H; Münzel T; Daiber A
Chem Biol Interact; 2019 Nov; 313():108834. PubMed ID: 31545955
[TBL] [Abstract][Full Text] [Related]
10. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
[TBL] [Abstract][Full Text] [Related]
11. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
Berthiaume JM; Wallace KB
Cardiovasc Toxicol; 2007; 7(3):178-91. PubMed ID: 17901561
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
[TBL] [Abstract][Full Text] [Related]
13. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities.
Li J; Wang PY; Long NA; Zhuang J; Springer DA; Zou J; Lin Y; Bleck CKE; Park JH; Kang JG; Hwang PM
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19626-19634. PubMed ID: 31488712
[TBL] [Abstract][Full Text] [Related]
14. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
Carvalho RA; Sousa RP; Cadete VJ; Lopaschuk GD; Palmeira CM; Bjork JA; Wallace KB
Toxicology; 2010 Apr; 270(2-3):92-8. PubMed ID: 20132857
[TBL] [Abstract][Full Text] [Related]
15. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
16. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction.
Berthiaume JM; Oliveira PJ; Fariss MW; Wallace KB
Cardiovasc Toxicol; 2005; 5(3):257-67. PubMed ID: 16244371
[TBL] [Abstract][Full Text] [Related]
17. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
[TBL] [Abstract][Full Text] [Related]
18. Exercise Training Prevents Doxorubicin-induced Mitochondrial Dysfunction of the Liver.
Hinkley JM; Morton AB; Ichinoseki-Sekine N; Huertas AM; Smuder AJ
Med Sci Sports Exerc; 2019 Jun; 51(6):1106-1115. PubMed ID: 30629044
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.
Chen X; Guo Z; Wang P; Xu M
Heart Lung Circ; 2014 Aug; 23(8):772-7. PubMed ID: 24685074
[TBL] [Abstract][Full Text] [Related]
20. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.
Ascensão A; Lumini-Oliveira J; Machado NG; Ferreira RM; Gonçalves IO; Moreira AC; Marques F; Sardão VA; Oliveira PJ; Magalhães J
Clin Sci (Lond); 2011 Jan; 120(1):37-49. PubMed ID: 20666733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
